Entero Therapeutics, Inc. (NASDAQ:ENTO) — Market Cap & Net Worth
Market Cap & Net Worth: Entero Therapeutics, Inc. (ENTO)
Entero Therapeutics, Inc. (NASDAQ:ENTO) has a market capitalization of $9.58 Million ($9.58 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27260 globally and #5637 in its home market, demonstrating a -13.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Entero Therapeutics, Inc.'s stock price $2.85 by its total outstanding shares 3361903 (3.36 Million). Also see ENTO total asset value for a full breakdown of the balance sheet.
Entero Therapeutics, Inc. Market Cap History: 2016 to 2026
Entero Therapeutics, Inc.'s market capitalization history from 2016 to 2026. Data shows change from $669.29 Billion to $9.58 Million (-69.99% CAGR). Also see Entero Therapeutics, Inc. (ENTO) cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Entero Therapeutics, Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.00% | #773 of 976 |
Weight: Entero Therapeutics, Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Entero Therapeutics, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Entero Therapeutics, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check ENTO live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ENTO by Market Capitalization
Companies near Entero Therapeutics, Inc. in the global market cap rankings as of September 18, 2026. Review ENTO tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Entero Therapeutics, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.34 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.87 Billion USD ( AU$84.62 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #187 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.09 Billion | $513.26 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.34 Billion | $774.61 |
| #457 | CSL Ltd | AU:CSL | $59.87 Billion | AU$174.41 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $145.62 |
Entero Therapeutics, Inc. Historical Marketcap From 2016 to 2026
Between 2016 and today, Entero Therapeutics, Inc.'s market cap moved from $669.29 Billion to $ 9.58 Million, with a yearly change of -69.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $9.58 Million | -38.84% |
| 2025 | $15.67 Million | +649.20% |
| 2024 | $2.09 Million | -85.19% |
| 2023 | $14.12 Million | -96.58% |
| 2022 | $412.30 Million | -97.98% |
| 2021 | $20.40 Billion | -85.10% |
| 2020 | $136.96 Billion | -6.73% |
| 2019 | $146.85 Billion | -14.05% |
| 2018 | $170.85 Billion | -66.73% |
| 2017 | $513.54 Billion | -23.27% |
| 2016 | $669.29 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Entero Therapeutics, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.58 Million USD |
| MoneyControl | $9.58 Million USD |
| MarketWatch | $9.58 Million USD |
| marketcap.company | $9.58 Million USD |
| Reuters | $9.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Entero Therapeutics, Inc.
Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the resear… Read more